SCHEMBL872886

SCHEMBL872886

CCOC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
LMNA P02545 1/20 0.52
PABPC1 P11940 1/20 0.50
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.45
KDM1A O60341 1/20 0.44
RCOR1 Q9UKL0 1/20 0.44
NPSR1 Q6W5P4 3/20 0.44
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PFKFB3 Q16875 2/20 0.43
PFKFB2 O60825 1/20 0.43
PFKFB1 P16118 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845295 0.90 KDM4E (0.61) KDM4ELMNAPABPC1ALDH1A1GAA
SCHEMBL844873 0.88 NPC1 (0.63) LMNAPABPC1ALDH1A1NPC1MAPK1
SCHEMBL10119687 0.86 CYP2C9 (0.44) PABPC1ALDH1A1NPC1MAPK1HTT
SCHEMBL872930 0.83 GAA (0.52) KDM4ELMNAPABPC1GAAMAPK1
SCHEMBL871771 0.81 PABPC1 (0.44) KDM4ELMNAPABPC1ALDH1A1GAA
SCHEMBL873856 0.81 HCRTR1 (0.45) ALDH1A1MAPK1HTTTSHRMEN1
SCHEMBL845110 0.81 ALDH1A1 (0.48) KDM4ELMNAALDH1A1HSD17B10KDM1A
SCHEMBL874313 0.80 MAPK1 (0.50) LMNAALDH1A1GAAMAPK1HTT
SCHEMBL845313 0.80 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APOLB
SCHEMBL10119595 0.80 SCN3A (0.43) NPC1PFKFB3PFKFB2PFKFB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed